10 papers analyzed
These studies suggest that the latest treatments for Parkinson's disease include drug repurposing, gene therapies, COMT inhibitors, clozapine, glutamate antagonists, neurotrophic factors, deep brain stimulation, adenosine A2A receptor antagonists, dopaminergic and nondopaminergic drugs, device-assisted therapies, and stem cell transplantation.
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms such as bradykinesia, tremor, rigidity, and postural instability, as well as non-motor symptoms like cognitive impairment and autonomic dysfunction. Traditional treatments primarily focus on dopamine replacement to manage symptoms, but they do not alter the disease's progression. Recent research has explored various novel therapeutic approaches aimed at both symptomatic relief and disease modification.
Recent advancements in the treatment of Parkinson's disease encompass a wide range of strategies, from novel dopaminergic and non-dopaminergic medications to gene and cell-based therapies. Disease-modifying approaches, including drug repurposing and immunotherapies, show promise in altering disease progression. Advanced surgical techniques like adaptive deep brain stimulation and stereotactic surgery offer significant symptomatic relief. Collectively, these innovations represent a hopeful future for more effective and comprehensive management of Parkinson's disease.
what is the current study on parental monitoring on adolescent's sleep outcome
what is research methodology
why is language unique to humans
How do we address global health challenges such as infectious diseases and pandemics?
How is pneumonia treated?
the General Data Protection Regulation (GDPR) for financial applications